Sickle Change

Researchers from Stanford University have used the CRISPR gene-editing tool to fix sickle cell anemia-causing mutations within the β-globin (HBB) gene in hematopoietic stem cells, Reuters reports.

"What we've finally shown is that we can do it. It's not just on the chalkboard," senior author Matthew Porteus from Stanford tells Reuters.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.